Loading...
Keywords
Last Name
Institution

Search Results (14)

Click the Why column to see why an item matched the search.

MatchTypeWhy
Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and pitfalls.Academic Article Why?
Transforming Performance of Clinical Trials in Pediatric Type 2 Diabetes: A Consortium Model.Academic Article Why?
Gemtuzumab ozogamicin in infants with AML: results from the Children's Oncology Group trials AAML03P1 and AAML0531.Academic Article Why?
Merging of the National Cancer Institute-funded cooperative oncology group data with an administrative data source to develop a more effective platform for clinical trial analysis and comparative effectiveness research: a report from the Children's Oncology Group.Academic Article Why?
Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease.Academic Article Why?
Cinacalcet studies in pediatric subjects with secondary hyperparathyroidism receiving dialysis.Academic Article Why?
Merging Children's Oncology Group Data with an External Administrative Database Using Indirect Patient Identifiers: A Report from the Children's Oncology Group.Academic Article Why?
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24.Academic Article Why?
High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group.Academic Article Why?
Investigation of ALPL variant states and clinical outcomes: An analysis of adults and adolescents with hypophosphatasia treated with asfotase alfa.Academic Article Why?
Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.Academic Article Why?
iAmHealthy: Rationale, design and application of a family-based mHealth pediatric obesity intervention for rural children.Academic Article Why?
Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.Academic Article Why?
The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.Academic Article Why?
Per Page    Page  of 1
Next
Prev
Search Criteria
  • Clinical Trials Phase 1
Filter by Type